Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI
Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI
Media
Menu
Menu
Menu
SUBSCRIBE TO OUR E-MAILS
Don't miss new updates on your email
Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders
Visit Us
2614 Boston Post Road, Suite #33AR
Guilford, CT 06437, USA
- +1 (203) 643-8060
- info@inveatx.com
Quick Links
Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders
Visit Us
2614 Boston Post Road Suite #33AR
Guilford, CT 06437, USA
- +1 (203) 643-8060
- info@inveatx.com
© 2024 Invea Therapeutics, Inc. All rights reserved | Privacy Policy | Terms of Use